Indivior Pharmaceuticals INDV
NASDAQ INDV
$38.19 -0.85 (-2.18%)
At close: Aug 20, 2026 · 1:46 PM UTC

Indivior Pharmaceuticals (INDV) Net Margin (2024 - 2026)

Indivior Pharmaceuticals (INDV) posted quarterly Net Margin of 28.08% for Q1 2026, up 1003.0% year-over-year from 2.55% in Q1 2025, and down 1.46% quarter-over-quarter from 28.49% in Q4 2025.

Indivior Pharmaceuticals (INDV) Net Margin (2024 - 2026) Analysis & Trends

Indivior Pharmaceuticals' Net Margin history runs 3 years deep, the most recent figure standing at 28.08% for Q1 2026.

  • In Q1 2026, Net Margin rose 1003.0% year-over-year to 28.08%; the TTM figure through Mar 2026 stood at 19.44% (up 2004.0% YoY), while the FY2025 annual figure was 16.95%, up 1636.0% from the prior year.
  • Net Margin for Q1 2026 stood at 28.08%, down from 28.49% in the prior quarter.
  • The five-year high for Net Margin was 28.49% in Q4 2025, with the low at 32.78% in Q2 2024.
  • The 3-year median for Net Margin is 13.38% (2025), against an average of 10.8%.
  • Peak annual rise in Net Margin reached 3874 bps in 2025, while the deepest fall reached 379 bps in 2025.
  • Indivior Pharmaceuticals' Net Margin stood at 7.02% in 2024, then jumped by 306 bps to 28.49% in 2025, then decreased by 1 bps to 28.08% in 2026.
  • Business Quant data shows INDV's Net Margin at 28.08% in Q1 2026, 28.49% in Q4 2025, and 13.38% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Haleon 43.91 Bn 42.95 Bn - -
2 Teva Pharmaceutical Industries 43.07 Bn 39.42 Bn 2.15 Bn -13.91%
3 Zoetis 31.54 Bn 29.86 Bn 1.05 Bn 35.09%
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn 9.28%
5 United Therapeutics 22.19 Bn 19.53 Bn 683.80 Mn 42.51%
6 Viatris 18.68 Bn 17.79 Bn 1.46 Bn -3.16%
7 Neurocrine Biosciences 15.50 Bn 15.11 Bn 935.80 Mn 15.06%
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn 3.95%
9 Dr Reddys Laboratories 10.12 Bn 9.96 Bn - -
10 Indivior Pharmaceuticals 4.54 Bn 4.32 Bn 294.00 Mn 35.57%

Historic Data

Download Data
DateValue
Jun 30, 2026 35.57%
Mar 31, 2026 28.08%
Dec 31, 2025 28.49%
Sep 30, 2025 13.38%
Jun 30, 2025 5.96%
Mar 31, 2025 18.05%
Dec 31, 2024 7.02%
Sep 30, 2024 7.17%
Jun 30, 2024 -32.78%
Mar 31, 2024 21.83%